Cervical Cancer Clinical Trial
Official title:
Cervical Cancer Screening: Video-based Tutorials for Skills Development of ANMs/ASHAs/PHWs
This study aims at creating video-based tutorials for developing skills in performing
cervical cancer screening using VIA for the Auxillary Nurse Midwives (ANMs), Accredited
Social Health Activists (ASHAs) and Primary Health Workers (PHWs). Cervical cancer screening
is mainly done by the following three methods: Visual inspection with acetic acid (VIA),
Cervical Smear Cytology (PAP) and HPV DNA test. VIA is a low cost, low resource cervical
cancer screening method and especially useful for low middle income countries (LMICs) like
India.
We propose to develop video-based tutorials, such that the ANMs/ASHAs/PHWs could be trained
in performing and interpreting VIA with the use of this tutorial. The ANMs/ASHAs/PHWs have
important roles in delivering health in rural/ semi urban areas and they will be trained
using this tutorial.
The video-based tutorials will be made according to the 'Spoken Tutorials' methodology,
developed at IIT Bombay. Video-based Tutorials has given skills based training to over 2 lakh
students in the past four years on IT based topics. The tutorials are made available online
free of cost. They are designed to be used without the need of an expert being physically
present.
Status | Recruiting |
Enrollment | 50 |
Est. completion date | September 2018 |
Est. primary completion date | September 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion Criteria: ANMs /ASHAs/PHWs attached to the TMC, District Hospitals and PHCs who
have not learned VIA based cervical cancer screening before. Exclusion Criteria: ANMs /ASHAs/PHWs attached to the TMC, District Hospitals and PHCs who have learnt VIA based cervical cancer screening before. |
Country | Name | City | State |
---|---|---|---|
India | Tata Memorial Hospital | Mumbai | Maharashtra |
Lead Sponsor | Collaborator |
---|---|
Tata Memorial Hospital |
India,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Clinical skills development | Scores will be assigned and the ability to correctly identify a VIA positive lesion will be assessed. | 1 year | |
Primary | Improvement in the Post training knowledge about cancer | Questionnaire: that will compare pre-training knowledge with post training and assess the improvement in the Post training knowledge about various aspects of cervical cancer viz., causes, various cervical cancer screening techniques, steps required to perform VIA etc. These will be measured with the help of test scores. Each question in the test will have marks assigned to it based on difficulty level. (Easy 1 mark, Intermediate 2 marks, Hard 3 marks, Very hard 4 marks). The ANMs will be assigned marks depending on the number of correct responses. The ANMs will have to take the tests before the training, immediately after the training, and three months after the training is complete. |
1 year | |
Secondary | Satisfaction to the video based tutorials | Questionnaire: that will assess the satisfaction level and feed back of the trainees with the course provided. The satisfaction level with the mode of teaching will be done on a survey based on a likert scale. |
1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06223308 -
A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Terminated |
NCT03367871 -
Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer
|
Phase 2 | |
Active, not recruiting |
NCT04537156 -
Efficacy, Immunogenicity and Safty Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
|
Phase 3 | |
Recruiting |
NCT03668639 -
Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT04242199 -
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
|
Phase 1 | |
Withdrawn |
NCT04806945 -
A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer
|
Phase 3 | |
Active, not recruiting |
NCT04185389 -
Long-Term Follow-Up of HPV FOCAL Participants
|
||
Withdrawn |
NCT03007771 -
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
|
Phase 1 | |
Completed |
NCT03384511 -
The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.
|
Phase 4 | |
Recruiting |
NCT05107674 -
A Study of NX-1607 in Adults With Advanced Malignancies
|
Phase 1 | |
Completed |
NCT05120167 -
Strategies for Endocervical Canal Investigation in Women With Abnormal Screening Cytology and Negative Colposcopy
|
N/A | |
Recruiting |
NCT05483491 -
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
|
Phase 1 | |
Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
Completed |
NCT05862844 -
Promise Women Project
|
N/A | |
Recruiting |
NCT04934982 -
Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IA1 With LVSI, IA2)
|
N/A | |
Recruiting |
NCT03876860 -
An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis
|
N/A | |
Completed |
NCT03652077 -
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
|
Phase 1 | |
Completed |
NCT00543543 -
Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)
|
Phase 3 | |
Terminated |
NCT04864782 -
QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer
|
Phase 2/Phase 3 | |
Recruiting |
NCT04226313 -
Self-sampling for Non-attenders to Cervical Cancer Screening
|
N/A |